Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Despite a solid partnership with Samsung SDI and BMW, and a clear roadmap for electrolyte production, the financials reveal a significant operating and net loss, which raises concerns. The Q&A highlighted potential future growth but lacked clarity on diversification and pilot line timelines, leading to uncertainties. The liquidity position appears stable, but the competitive and regulatory environment poses risks. Given the mixed signals, the stock is likely to remain neutral in the short term as investors weigh the potential against the financial challenges.
Revenue $21.7 million in 2025, an increase of $1.6 million compared to 2024. The year-over-year growth was driven primarily by work performed under the line installation agreement with SK On, reflecting continued execution against customer programs.
Operating Expenses $122.6 million in 2025 compared to $125.5 million in 2024. The year-over-year decrease reflects cost discipline partially offset by investments in research and development as well as equipment purchases and services performed in support of the SK On agreements.
Operating Loss $100.8 million in 2025.
Net Loss $93.4 million or $0.51 per share in 2025.
Capital Expenditures (CapEx) $10.2 million in 2025, primarily representing costs associated with planned construction of the continuous electrolyte production pilot line.
Cash Investment $84.5 million for fiscal year 2025, reflecting continued focus on prioritization and disciplined capital allocation.
Total Liquidity $336.5 million as of December 31, 2025, an increase of $9 million compared to year-end 2024.
Contract Assets and Accounts Receivable $9.6 million as of December 31, 2025.
Total Current Liabilities $16.8 million as of December 31, 2025.
Net Proceeds from ATM Program $88.8 million in 2025, including $56 million raised during the fourth quarter.
Electrolyte Sampling: Continued sampling efforts with demand from existing and new customers. Joint evaluation agreement with Samsung SDI and BMW to advance all solid-state batteries. Electrolyte provided to SDI for joint evaluation activities.
Electrolyte Development Road Map: Progressed towards installation of continuous electrolyte production pilot line. Ordered long lead equipment and conducted detailed design. Expected installation and commissioning by end of 2026.
Electrolyte Innovation and Performance: Enhanced understanding of electrolyte performance, identified improvements, and tailored electrolyte to customer specifications. Demonstrated technology in BMW i7 test vehicle.
Partnerships: Joint evaluation agreement with Samsung SDI and BMW. Agreements with SK On for research, line installation, and electrolyte supply.
Commercial Scale Production: Plans to pursue partnership for commercial scale electrolyte production in Korea, targeting facility capable of producing up to 500 metric tons annually.
Financial Performance: 2025 revenue of $21.7 million, up $1.6 million from 2024. Operating expenses decreased to $122.6 million. Net loss of $93.4 million. Total liquidity at $336.5 million.
Capital Expenditures: 2025 CapEx of $10.2 million for continuous electrolyte production pilot line. 2026 cash investment expected between $85 million to $100 million.
Financial Discipline: Focus on disciplined capital allocation and extending financial runway. Completed $130 million registered direct offering to strengthen liquidity.
Commercialization Goals: Advancing electrolyte technology and production capacity. Targeting 75 metric tons annual production by end of 2026.
Financial Losses: The company reported an operating loss of $100.8 million and a net loss of $93.4 million for 2025, indicating ongoing financial challenges.
High Operating Expenses: Operating expenses for 2025 were $122.6 million, reflecting significant costs associated with research and development, equipment purchases, and agreements with SK On.
Capital Expenditure Requirements: The company incurred $10.2 million in capital expenditures in 2025 and expects to invest $85 million to $100 million in 2026, which could strain liquidity.
Dependence on Partnerships: The company’s progress and commercialization efforts are heavily reliant on partnerships with entities like SK On, Samsung SDI, and BMW, posing risks if these partnerships face challenges or fail.
Technological and Development Risks: The company is still in the development phase for its continuous electrolyte production pilot line and other technologies, with potential delays or failures impacting commercialization timelines.
Market Competition: The company faces competitive pressures in the solid-state battery market, requiring continuous innovation to maintain a competitive edge.
Regulatory and Compliance Risks: The company operates in a highly regulated industry, and any changes in regulations or compliance failures could adversely impact operations.
Liquidity Management: While the company raised $88.8 million in 2025 and completed a $130 million offering in 2026, maintaining liquidity remains critical to support operations and commercialization efforts.
2026 Cash Investment: Expected to range between $85 million to $100 million, reflecting focus on advancing electrolyte development road map, commissioning continuous pilot line, and maintaining financial discipline.
Electrolyte Development Road Map: Plan to commission continuous electrolyte production line by the end of 2026, designed to expand annual production capacity to up to 75 metric tons. Intend to pursue a partnership for commercial scale electrolyte production in Korea, targeting a facility capable of producing up to 500 metric tons annually.
Partnerships and Validation Activities: Expect to continue providing Samsung SDI with electrolyte under the joint evaluation agreement. Plan to complete site acceptance testing of the SK On line in Q1 2026, followed by validation activities and electrolyte delivery to SK On.
Electrolyte Product Competitiveness: Focus on enhancing understanding of electrolyte performance relative to other sulfide electrolyte products to develop competitive, differentiated products and secure long-term customers. Utilize Electrolyte Innovation Center (EIC) for development and testing.
Financial Discipline and Liquidity: Maintain strong balance sheet to support commercialization. Successfully completed a $130 million registered direct offering to strengthen liquidity and strategic flexibility.
The selected topic was not discussed during the call.
Despite a solid partnership with Samsung SDI and BMW, and a clear roadmap for electrolyte production, the financials reveal a significant operating and net loss, which raises concerns. The Q&A highlighted potential future growth but lacked clarity on diversification and pilot line timelines, leading to uncertainties. The liquidity position appears stable, but the competitive and regulatory environment poses risks. Given the mixed signals, the stock is likely to remain neutral in the short term as investors weigh the potential against the financial challenges.
Despite a new partnership with Samsung SDI and BMW, the company faces significant financial challenges, including a revenue decline and high operating losses. The reduced cash investment guidance reflects fiscal discipline, but ongoing reliance on partnerships and manufacturing risks present uncertainties. With no guidance provided, the market may react negatively.
The earnings call summary shows mixed indicators: a slight revenue increase and reduced operating expenses, but ongoing net losses and uncertainties in revenue trajectory beyond 2025. Partnerships with major companies and a DOE grant are positives, but supply chain and competitive pressures pose risks. The Q&A reveals unclear guidance on future revenue, which adds to uncertainty. Given these mixed signals and the absence of clear catalysts for strong movement, the stock price is likely to remain stable in the short term, resulting in a neutral sentiment.
The earnings call reveals several concerns: an EPS miss, significant operating and net losses, and uncertainty over DOE funding. Despite revenue growth and strong liquidity, the company faces macro challenges and a competitive landscape shift. The Q&A session highlighted unclear management responses on tariffs and strategic focus. Although there are positive elements like partnerships and revenue growth, the overall sentiment is negative due to financial underperformance and strategic uncertainties.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.